Bausch Health Companies (BHC) Revenue (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Revenue data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 11.73% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $10.5 billion (up 8.22% YoY), and the FY2025 full-year result was $10.3 billion, up 6.66% from the prior year.
• Revenue fell to $2.5 billion in Q1 2026, from $2.8 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.8 billion in Q4 2025 to a low of $1.9 billion in Q1 2022.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2025 frame the typical range for Revenue.
• Across the five-year window, Revenue slumped 69.71% in 2022 and grew 12.15% in 2024, its largest moves.
• Tracing BHC's Revenue over 5 years: stood at $2.2 billion in 2022, then grew by 9.8% to $2.4 billion in 2023, then grew by 6.27% to $2.6 billion in 2024, then climbed by 9.26% to $2.8 billion in 2025, then decreased by 9.73% to $2.5 billion in 2026.
• Business Quant data shows BHC's Revenue at $2.5 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.7 billion in Q3 2025.